David John Smith - 29 Feb 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Mar 2024, 09:55:45 UTC
Prior SEC filing
31 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David John Smith

Key filing fact

David John Smith filed Form 4 for Glimpse Group, Inc. (VRAR) on 05 Mar 2024.

Key facts

  • This page summarizes David John Smith's Form 4 filing for Glimpse Group, Inc. (VRAR).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Mar 2024, 09:55.

Change

  • Previous filing in this sequence was filed on 31 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRAR transaction Derivative

Stock Option (Right to Purchase)

Disposed to Issuer

Transaction value
$0
Shares
-64,349
Change %
-100%
Price
$0.000000*
Shares after
0
Date
29 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
64,349
Exercise price
Footnotes
F1, F2
VRAR transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value
$0
Shares
+51,480
Change %
Price
$0.000000
Shares after
51,480
Date
01 Mar 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
51,480
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the forfeiture of vested options to purchase an aggregate of 64,349 shares of common stock ("CS") granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 4,500 shares of CS and 20,004 shares of CS granted on January 6, 2023 and September 1, 2018, respectively, with exercise prices of $7.00/share and $4.00/share, respectively, (ii) 6,668 shares of CS and 14,232 shares of CS granted on September 1, 2019 and January 1, 2020, respectively, with exercise prices of $4.00/share and $4.50/share, respectively, (iii) 1,333 shares of CS and 667 shares of CS granted on May 1, 2020 and July 1, 2020, respectively, with an exercise price of $4.50/share, (iv) 889 shares of CS and 11,556 shares of CS granted on November 1, 2020 and January 1, 2021, with an exercise price of $4.50/share, and (v) 4,500 shares of CS granted on April 1, 2023 with an exercise price of $7.00/share.

Footnote F2

The options in footnote (1) were to expire 10 years from their respective grant dates.

Footnote F3

Mr. Smith was granted options to purchase an aggregate of 51,480 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 17,160 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .